AzTrials
AzTrials

Effect of Pericardial Closure on the Right Ventricular Function Post Cardiac SurgeryNCT07836426

Does the Pericardial Closure Reduces Early Right Ventricular Dysfunction After Cardiac Surgery: A Randomized Controlled Trial

A study testing close pericardium in people with Effect of Pericardial Closure on the Right Ventricular Function Post Cardiac Surgery and Open Heart Surgery, run by Assiut University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The right ventricular (RV) function has a major influence on the outcomes of cardiac surgery[1,2]. Also affects the prognosis of patients undergoing heart surgery, where the development of right ventricular failure after surgery is linked to higher rates of morbidity and mortality[3]. Read more about this study

Who is it for?
Any age
What is being tested?
close pericardium
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteEgypt
Study dates
10 Dec 2026to Dec 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients undergoing following surgeries
  • aortic valve replacement (AVR).
  • mitral valve replacement (MVR).
  • combined coronary and/or valvular heart surgeries.
  • coronary artery by-pass graft (CABG).

Who cannot join

  • • right ventricular dysfunction
  • RV dilatation (RV diameter > 4.5)
  • RV infarction
  • pacemaker stimulation,
  • severe left heart insufficiency (LV-EF ≤ 40%).
  • tricuspid valve insufficiency > 2°.
Show all 11Show fewer
  • pulmonary valve insufficiency ≥2°,
  • atrial fibrillation/flutter,
  • pulmonary hypertension,
  • state after pulmonary artery embolism.
  • chronic obstructive pulmonary disease > GOLD 2, prior cardiac surgery.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Abdelrahamn Hamed Abdelrahman hamed contact

00201060048430

abdelrahman.hamed.ed@gmail.com

Egypt1 site
  • Assiut University hospital

    Asyut

    Assiut Assuit university hospital, 00201060048430, abdelrahman.hamed.ed@gmail.com

    abdelrahaman hamed Ahmed

Other trials in Egypt

About this study

The right ventricular (RV) function has a major influence on the outcomes of cardiac surgery[1,2]. Also affects the prognosis of patients undergoing heart surgery, where the development of right ventricular failure after surgery is linked to higher rates of morbidity and mortality[3]. Significant clinical consequences result from perioperative impairment of RV function, including increased need for inotropic support, prolonged intensive care unit admission, higher rates of hospital readmission, and a higher risk of in-hospital mortality.[2,4]. Regardless of the use of cardiopulmonary bypass, longitudinal evaluations of RV systolic function, such as tricuspid annular plane systolic excursion (TAPSE) and tricuspid annular systolic velocity (TASV/S'), frequently decrease following elective coronary artery bypass grafting (CABG) [6,7]. Loss of pericardial restriction during pericardiotomy, ischemia from inadequate myocardial protection, and postoperative adhesions that modify RV shape and contraction patterns are theories explaining these perioperative alterations [4,8]. This study employed standard transthoracic echocardiography and speckle-tracking deformation analysis for the assessment of the effect of closing the pericardium on RV function post operatively versus leaving it open.

Being tested
close pericardium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • close pericardiumProcedure or surgery

    close pericardium by continuous sutures before sternal closure

Study groups in NCT07836426
Study groupRoleWhat they receive
interventionExperimentalclosed pericardium
Receives: Procedure: close pericardium
controlNo interventionopen pericardium

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Tricuspid annular plane systolic excursion (TAPSE)

    to asses the effect of pericardial closure on the right ventricular function

    Measured: 3 months

  2. Tricuspid annular systolic velocity TASV/S'

    to asses the effect of pericardial closure on right ventricular function

    Measured: 3 month

Secondary outcomes (1)
  1. the postoperative LV function after pericardial closure vs. open pericardium

    by assessing ejection fraction by early postoperative echocardiography

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Sep 2026
  2. Study start10 Dec 2026 (estimated)
  3. Primary completionDec 2029 (estimated)
  4. Study completionDec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Care provider, Outcomes assessor
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07836426
Sponsor's protocol ID
Pericardial Closure postop
Status last verified
Sep 2026
First submitted
11 Sep 2026
Last updated
23 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: according to the need of explanation

Publications

  • Bootsma IT, Scheeren TWL, de Lange F, Jainandunsing JS, Boerma EC. The Reduction in Right Ventricular Longitudinal Contraction Parameters Is Not Accompanied by a Reduction in General Right Ventricular Performance During Aortic Valve Replacement: An Explorative Study. J Cardiothorac Vasc Anesth. 2020 Aug;34(8):2140-2147. doi: 10.1053/j.jvca.2020.01.012. Epub 2020 Jan 15.

    PubMed 32139346
  • Merlo A, Cirelli C, Vizzardi E, Fiorendi L, Roncali F, Marino M, Merlo M, Senni M, Sciatti E. Right Ventricular Dysfunction before and after Cardiac Surgery: Prognostic Implications. J Clin Med. 2024 Mar 11;13(6):1609. doi: 10.3390/jcm13061609.

    PubMed 38541835
  • Breuer H, Sales MC, Ramnath NWM, Shieba Y, Kolashov A, Moza A, Tewarie L, Zayat R, Hatam N. Pericardial Closure Preserves Early Right Ventricular Function After Cardiac Surgery: A Retrospective Cohort Study. J Cardiovasc Dev Dis. 2025 Oct 31;12(11):431. doi: 10.3390/jcdd12110431.

    PubMed 41295357

Questions about this trial

What is this clinical trial studying?

A study testing close pericardium in people with Effect of Pericardial Closure on the Right Ventricular Function Post Cardiac Surgery and Open Heart Surgery, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Abdelrahamn Hamed Abdelrahman hamed (00201060048430, abdelrahman.hamed.ed@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Tricuspid annular plane systolic excursion (TAPSE) (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07836426, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in